Hope for women with late-stage womb cancer as ‘powerful’ treatment receives NHS approval
A groundbreaking immunotherapy medication has received NHS approval, bringing new possibilities for women facing late-stage womb cancer.The drug pembrolizumab will be available to roughly 2,100 patients yearly throughout…
